2023
9.15.2023
Brad Pentelute and his lab compel the anthrax delivery system to deliver antibody and peptide variants into cells to treat cancer. (Pentelute lab)
8.11.2023
MIT engineers developed a new way to create these arrays, by scaffolding quantum rods onto patterned DNA. (Bathe lab)
8.2.2023
SMART researchers find the enzyne RlmN, which directly senses chemical and environmental stresses, can be targeted in drug development. (Dedon lab)
7.27.2023
MIT researchers find timing and dosage of DNA-damaging drugs are key to whether a cancer cell dies or enters senescence. (Yaffe lab)
6.26.2023
SMART researchers combine rifaximin and clarithromycin to effectively restore the latter drug's efficacy. (Dedon lab)
5.1.2023
Keystone Science Lecturer Bevin Engelward, Sc.D., described models and screening tests she developed to explain how exposures affect DNA stability. (Engelward lab)
4.25.2023
The new diagnostic, which is based on analysis of urine samples, could also be designed to reveal whether a tumor has metastasized. (Bhatia lab)
2.23.2023
New modeling tool enables rapid design of effective and equitable policy combinations. (Selin lab)
1.31.2023
The biological engineer is recognized for his scientific achievements over the course of his career. (Dedon lab)
1.20.2023
SOT Education Award
This award recognizes an individual who is distinguished by the teaching and training of toxicologists and who has made significant contributions to education in the broad field of toxicology.
- Bevin Page Engelward, ScD, Massachusetts Institute of Technology
1.20.2023
This MIT researcher gained recognition for her work on tracing how the toxin NDMA damages genes, and how the DNA might repair itself. (Essigmann lab)
1.11.2023
Biologists have mapped out more than 300 protein kinases and their targets, which they hope could yield new leads for cancer drugs. (Yaffe lab)
1.2.2023
Using these engineered proteins, researchers can record histories that reveal when certain genes are activated or how cells respond to a drug. (Boyden lab)
